矿物质皮质体系统,炎症,高血压和病之间的相互作用
Eviatar Fields1, Ernesto L Schiffrin1,2,3
1Department of Medicine, McGill University, Quebec, Canada.
Kidney360
|July 22, 2025
概括
阿尔多素通过影响平衡和引起氧化应激,影响高血压和慢性病 (CKD). 阻止其影响可以降低血压,并保护脏等器官.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
- 心血管科学 心血管科学
背景情况:
- 阿尔多是一个来自上腺质细胞的激素,它调节电解质平衡和血压.
- 它是由血管新素II (AngII),上腺皮质激素 (ACTH) 和 (K+) 刺激,并由尿素抑制.
- 阿尔多斯特通过核矿物质皮质体受体 (MRs) 和潜在的膜受体,如G蛋白结合雌激素受体 (GPER30) 发挥作用.
研究的目的:
- 审查阿尔多斯在高血压和慢性病 (CKD) 中的多方面的作用.
- 强调阿尔多斯对脏的影响,包括其基因组和非基因组作用.
- 讨论参与阿尔多素有害影响的信号通路,例如氧化应激,炎症和纤维化.
主要方法:
- 对阿尔多素的生理和病理作用的文献综述.
- 对阿尔多斯特的作用机制的分析,包括受体介导作用.
- 检查信号通路 (氨酸激酶,MAPK) 和下游后果 (氧化应激,炎症,纤维化).
主要成果:
- 阿尔多激素促进远端脏中Na+和水的保留,影响电解质和体积的控制.
- 它刺激氧化应激,炎症和血管,和心脏中的纤维化.
- 阿尔多素有助于内皮功能障碍和高血压的进展.
结论:
- 阻断矿物质皮质类受体 (MR) 或抑制阿尔多斯特生成有效降低血压.
- 针对阿尔多素通路的治疗策略可以保护目标器官免受损伤,并减少CKD的进展.
- 了解阿尔多的复杂作用对于管理高血压和脏疾病至关重要.
相关概念视频
01:29Hypertension II: Pathophysiology
85
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
85
01:33Hormonal Regulation
33.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.7K
01:18Hypertension and Regulation of Blood Pressure
3.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.1K
01:17Hormonal Regulation of Blood Pressure
3.2K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
3.2K
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
891
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
891
01:25Antihypertensive Drugs: Direct Renin Inhibitors
830
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
830